“Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture” (2026) Tikrit Journal of Pharmaceutical Sciences, 20(1), pp. 20–32. doi:10.25130/tjphs.2026.20.1.3.20.32.